Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanmei Hu

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Bioorganic Chemistry|June 20, 2020
Development of broad-spectrum enterovirus antivirals based on quinoline scaffoldRami Musharrafieh, Naoya Kitamura, Yanmei Hu, et al.
The Journal of Physical Chemistry. A|September 13, 2024
Triple Electron Attachments with a New Intermediate-Hamiltonian Fock-Space Coupled-Cluster MethodYanmei Hu, Zhifan Wang, Fan Wang, et al.
ACS Infectious Diseases|July 22, 2020
Pharmacological Characterization of the Mechanism of Action of <b>R523062</b>, a Promising Antiviral for Enterovirus D68Chunlong Ma, Yanmei Hu, Jiantao Zhang, et al.
International Journal of Molecular Sciences|November 13, 2025
Unveiling Berberine's Therapeutic Mechanisms Against Hepatocellular Carcinoma via Integrated Computational Biology and Machine Learning Approaches: AURKA and CDK1 as Principal TargetsYuyang Wu, Yanmei Hu, Haicui Liu, et al.
Journal of Medical Virology|January 26, 2022
Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cellYanmei Hu, Hyunil Jo, William F DeGrado, et al.
Protein Science : a Publication of the Protein Society|September 17, 2016
Solution structure of protein synthesis initiation factor 1 from Pseudomonas aeruginosaYanmei Hu, Alejandra Bernal, James M Bullard, et al.
ACS Infectious Diseases|September 19, 2019
A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68Chunlong Ma, Yanmei Hu, Jiantao Zhang, et al.
Current Medicinal Chemistry|July 10, 2018
Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay DevelopmentJiantao Zhang, Yanmei Hu, Rami Musharrafieh, et al.
Current Drug Discovery Technologies|January 21, 2015
High Throughput Screen Identifies Natural Product Inhibitor of Phenylalanyl-tRNA Synthetase from Pseudomonas aeruginosa and Streptococcus pneumoniaeYanmei Hu, Stephanie O Palmer, Hector Munoz, et al.
Journal of Medicinal Chemistry|May 27, 2022
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like ProteaseHaozhou Tan, Yanmei Hu, Prakash Jadhav, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Bioorganic Chemistry|June 20, 2020
Development of broad-spectrum enterovirus antivirals based on quinoline scaffoldRami Musharrafieh, Naoya Kitamura, Yanmei Hu, et al.
The Journal of Physical Chemistry. A|September 13, 2024
Triple Electron Attachments with a New Intermediate-Hamiltonian Fock-Space Coupled-Cluster MethodYanmei Hu, Zhifan Wang, Fan Wang, et al.
ACS Infectious Diseases|July 22, 2020
Pharmacological Characterization of the Mechanism of Action of <b>R523062</b>, a Promising Antiviral for Enterovirus D68Chunlong Ma, Yanmei Hu, Jiantao Zhang, et al.
International Journal of Molecular Sciences|November 13, 2025
Unveiling Berberine's Therapeutic Mechanisms Against Hepatocellular Carcinoma via Integrated Computational Biology and Machine Learning Approaches: AURKA and CDK1 as Principal TargetsYuyang Wu, Yanmei Hu, Haicui Liu, et al.
Journal of Medical Virology|January 26, 2022
Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cellYanmei Hu, Hyunil Jo, William F DeGrado, et al.
Protein Science : a Publication of the Protein Society|September 17, 2016
Solution structure of protein synthesis initiation factor 1 from Pseudomonas aeruginosaYanmei Hu, Alejandra Bernal, James M Bullard, et al.
ACS Infectious Diseases|September 19, 2019
A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68Chunlong Ma, Yanmei Hu, Jiantao Zhang, et al.
Current Medicinal Chemistry|July 10, 2018
Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay DevelopmentJiantao Zhang, Yanmei Hu, Rami Musharrafieh, et al.
Current Drug Discovery Technologies|January 21, 2015
High Throughput Screen Identifies Natural Product Inhibitor of Phenylalanyl-tRNA Synthetase from Pseudomonas aeruginosa and Streptococcus pneumoniaeYanmei Hu, Stephanie O Palmer, Hector Munoz, et al.
Journal of Medicinal Chemistry|May 27, 2022
Progress and Challenges in Targeting the SARS-CoV-2 Papain-like ProteaseHaozhou Tan, Yanmei Hu, Prakash Jadhav, et al.
Pageof 11